SUBSCRIBERS

Corporate digest

Published Tue, Jul 7, 2015 · 09:50 PM

Cordlife Group

CORDLIFE Group said on Tuesday that it has rejected an unsolicited third party offer for its shares in China Cord Blood Corporation and convertible notes due 2017. Instead, it will proceed with an earlier plan to sell them to Hang Seng-listed healthcare company Golden Meditech.

Digiland International

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here